Congratulations to our ESR, Helena Macut, on winning
the Best Poster Award at
10th Joint Meeting on medicinal chemistry, June 25-28, 2017, Dubrovnik, Croatia
Only three poster were selected among 200 posters and Helena was invited to deliver a flash presentation on
“Design, synthesis, and in vitro evaluation of modulators of the auto-regulatory domain of an enzyme involved in glycolysis pathway”.
Congratulations to our ESR, Cristofori Virginia, on winning
the First Year Prize Talk of the Postgraduate School, CLSM – Medical Sciences and Nutrition, University of Aberdeen, UK
with her PhD presentation in
“Structure-based design and synthesis of new PFKFB3 kinase inhibitors as candidate therapeutics for treating atherosclerosis“.
A short article published in
PLATINUM – BUSINESS LEADERS
November 2016 complimentary copy with today’s II Sole 24 Ore
Click here for the complete volume (both in Italian and English, article on page 110)
get in touch with us!
leave your e.mail and receive all the news about MOGLYNET PhD Programme
(+39) 02 220.127.116.11 / 81
We are the MOGLYNET-PhD programme in drug discovery and development.
The Horizon 2020 MSCA joint doctoral project MOGLYNET (“Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study”) is run by a Consortium of Universities in cooperation with Industries and Associations operating in the Pharma sector with the aim to offer an innovative PhD level training in Drug Discovery and Development to 12 Early Stage Researchers